Side-by-side versus stent-in-stent deployment in bilateral endoscopic metal stenting for malignant hilar biliary obstruction.
Abstract
BACKGROUND
The clinical differences between side-by-side and stent-in-stent deployment using a self-expanding metal stent for hilar malignant
obstruction have not been evaluated.
AIMS
The purpose of this study was to compare the clinical features between side-by-side and stent-in-stent deployment.
METHODS
We compared side-by-side and stent-in-stent deployment in 52 consecutive patients with malignant hilar biliary obstruction
who underwent endoscopic bilateral drainage using self-expanding metal stent. Side-by-side deployment (SBS group) was performed
in 28 patients from 2002 to 2005, and stent-in-stent deployment (SIS group) in 24 patients from 2006 to 2010. Technical success,
functional success, complications, stent occlusion and cumulative stent patency in the SBS and SIS groups were evaluated and
compared retrospectively.
RESULTS
There were no significant inter-group differences in technical success (SBS vs. SIS, 89 vs. 100 %, respectively), functional
success (96 vs. 100 %), early complications (11 vs. 4 %), late complications (32 vs. 8 %) or stent occlusion (20 vs. 42 %).
The incidence of complications was significantly higher for SBS than for SIS (44 vs. 13 %; p = 0.016). Cumulative stent patency
was significantly better for SBS than for SIS (log-rank, p = 0.047). SBS was not associated with significantly longer cumulative
stent patency in univariate Cox proportional hazard analysis (HR 0.35; 95 % CI 0.12-1.03; p = 0.056) and multivariate analysis
(HR 0.39; 95 % CI 0.13-1.16; p = 0.090).
CONCLUSIONS
The incidence of complications is higher for side-by-side than stent-in stent deployment in bilateral metal stenting. In terms
of cumulative stent patency, side-by-side deployment tends to be more effective than stent-in-stent deployment.
Links
Authors
Naitoh I, Hayashi K, Nakazawa T, Okumura F, Miyabe K, Shimizu S, Yoshida M, Yamashita H, Ohara H, Joh T
Institution
Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.
Source
Digestive diseases and sciences 57:12 2012 Dec pg 3279-85MeSH
AdultAged
Aged, 80 and over
Bile Duct Neoplasms
Cholestasis
Endoscopy, Gastrointestinal
Female
Humans
Male
Middle Aged
Risk Factors
Stents
Pub Type(s)
Clinical TrialJournal Article
Language
eng
PubMed ID
22732832
Log In

